High multiplex analysis of the immune microenvironment in bone marrow trephine samples using GeoMX™ digital spatial profiling von Koldej, R.M., Ritchie, D.S.

Volltext

T cell CD62L expression following nivolumab therapy is associated with response to rituximab‐nivolumab in treatment naïve follicular lymphoma: the 1st FLOR study von Koldej, R. M., Barraclough, A., Lee, S. T., Morgan, H., Holzwart, N., Koshy, M., Smith, C., Chong, G., Gilbertson, M., Keane, C., Ting, S., Churilov, L., Ritchie, D. S., Hawkes, E. A.

Volltext

P799: SPATIAL ANALYSIS IDENTIFIES A SPECTRUM OF IMMUNE DYSREGULATION IN ACQUIRED BONE MARROW FAILURE CONDITIONS von Koldej, R., Prabahran, A., Tan, C. W., Davis, M., Ritchie, D.

Volltext

COMPARISON OF INNATE IMMUNITY CHANGES FOLLOWING IBRUTINIB AND VENETOCLAX TREATMENT OF RELAPSED CHRONIC LYMPHOCYTIC LEUKAEMIA von Mason, K., Sharpe, C., Davis, J., Koldej, R., Tam, C., Ritchie, D.

Volltext

Volatile anaesthesia and peri‐operative outcomes related to cancer: a feasibility and pilot study for a large randomised control trial von Dubowitz, J. A., Cata, J. P., De Silva, A. P., Braat, S., Shan, D., Yee, K., Hollande, F., Martin, O., Sloan, E. K., Riedel, B., Hiller, J., Koldej, R., Leslie, K., Myles, P., Buggy, D., Wigmore, T., Gottumukkala, V., Sessler, D. I.

Volltext

Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production von Koldej, R., Cmielewski, P., Stocker, A., Parsons, D. W., Anson, D. S.

Volltext

Lentivirus-mediated gene transfer to the rat, ovine and human cornea von Parker, D G A, Kaufmann, C, Brereton, H M, Anson, D S, Francis-Staite, L, Jessup, C F, Marshall, K, Tan, C, Koldej, R, Coster, D J, Williams, K A

Volltext

P08.44 Preoperative serum microRNA profiles as a diagnostic tool in glioma von Morokoff, A., Bennett, I., Paradiso, L., Luwor, R., Koldej, R., Li, J., Ma, C., Drummond, K., Kaye, A., Siegal, T.

Volltext

IMMUNE PRIMING WITH NIVOLUMAB FOLLOWED BY NIVOLUMAB & RITUXIMAB IN 1 ST LINE TREATMENT OF FOLLICULAR LYMPHOMA: THE PHASE 2 1 ST FLOR STUDY von Hawkes, E. A., Lee, S. T., Chong, G., Gilbertson, M., Grigg, A., Churilov, L., Fancourt, T., Keane, C., Ritchie, D., Koldej, R., Agarwal, R., Manos, K., Smith, C., Houdyk, K., Hawking, J., Barraclough, A.

Volltext

PS1118 IDENTIFICATION OF MIRNA SIGNATURES CORRELATING WITH CLINICAL OUTCOMES IN APLASTIC ANAEMIA von Chee, L., Koldej, R., Chung, J., Ludford‐Menting, M., Ritchie, D.

Volltext

IMMUNE PRIMING WITH NIVOLUMAB FOLLOWED BY NIVOLUMAB & RITUXIMAB IN 1ST LINE TREATMENT OF FOLLICULAR LYMPHOMA: THE PHASE 2 1ST FLOR STUDY von Hawkes, E A, Lee, S T, Chong, G, Gilbertson, M, Grigg, A, Churilov, L, Fancourt, T, Keane, C, Ritchie, D, Koldej, R, Agarwal, R, Manos, K, Smith, C, Houdyk, K, Hawking, J, Barraclough, A

Volltext

Impact of age‐, cancer‐, and treatment‐driven inflammation on T cell function and immunotherapy von Quinn, Kylie M., Kartikasari, Apriliana E. R., Cooke, Rachel E., Koldej, Rachel M., Ritchie, David S., Plebanski, Magdalena

Volltext

Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals von Mehta, Palak H, Trollope, Gemma S, Leung, Patrick, Chinni, Shivali Savita, Iasinskaia, Anna, Harrison, Aaron J, Hughes‐Parry, Hannah, Jenkins, Misty R, Kershaw, Michael H, Jaworowski, Anthony, Slaney, Clare Y, Koldej, Rachel M, Ritchie, David S, Quinn, Kylie M

Volltext

Time-Limited Ibrutinib and Tisagenlecleucel Is Highly Effective in the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma, Including Those with TP53 Mutated and... von Minson, Adrian, Hamad, Nada, Cheah, Chan Y., Tam, Constantine S., Blombery, Piers, Westerman, David A, Lade, Stephen, Ritchie, David, Koldej, Rachel M, Anderson, Mary Ann, Khot, Amit, Seymour, John F., Robertson, Molly, Caldwell, Imogen R, Ryland, Georgina L, Xie, Jing, Morgan, Huw, Dickinson, Michael

Volltext

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA von Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Roberts, Ainslie, Clements, Peter R, Dunning, Kylie, Byers, Sharon

Volltext

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA-1 von Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Ainslie Roberts, Clements, Peter R, Dunning, Kylie, Byers, Sharon

Volltext bestellen

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA-0 von Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Ainslie Roberts, Clements, Peter R, Dunning, Kylie, Byers, Sharon

Volltext bestellen

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA-3 von Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Ainslie Roberts, Clements, Peter R, Dunning, Kylie, Byers, Sharon

Volltext bestellen

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA-5 von Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Ainslie Roberts, Clements, Peter R, Dunning, Kylie, Byers, Sharon

Volltext bestellen

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA-4 von Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Ainslie Roberts, Clements, Peter R, Dunning, Kylie, Byers, Sharon

Volltext bestellen